Table 1 Main characteristics of participants from Stop Mpox
Mpox virus infection status | |||
|---|---|---|---|
All N = 113 | Negative N = 106 | Positive N = 7 | |
Median age (IQR) | 35.00 [30.00;43.00] | 35.00 [30.00;43.00] | 37.00 [34.00;48.50] |
Gender | |||
Cis man | 89 (78.76%) | 82 (77.36%) | 7 (100.00%) |
Trans woman | 17 (15.04%) | 17 (16.04%) | 0 (0.00%) |
Non binary person | 3 (2.65%) | 3 (2.83%) | 0 (0.00%) |
DK/DA | 4 (3.54%) | 4 (3.77%) | 0 (0.00%) |
Sexual orientation | |||
Gay | 84 (74.34%) | 77 (72.64%) | 7 (100.00%) |
Heterosexual | 8 (7.08%) | 8 (7.55%) | 0 (0.00%) |
Bisexual | 12 (10.62%) | 12 (11.32%) | 0 (0.00%) |
Other | 3 (2.65%) | 3 (2.83%) | 0 (0.00%) |
DK/DA | 6 (5.31%) | 6 (5.66%) | 0 (0.00%) |
Country of birth | |||
Spain | 37 (32.74%) | 34 (32.08%) | 3 (42.86%) |
Other | 72 (63.72%) | 68 (64.15%) | 4 (57.14%) |
DK/DA | 4 (3.54%) | 4 (3.77%) | 0 (0.00%) |
HIV positive | |||
Yes | 44 (38.94%) | 41 (38.68%) | 3 (42.86%) |
No | 61 (53.98%) | 58 (54.72%) | 3 (42.86%) |
I don’t know my HIV status | 1 (0.88%) | 0 (0.00%) | 1 (14.29%) |
I do not want to answer | 1 (0.88%) | 1 (0.94%) | 0 (0.00%) |
DK/DA | 6 (5.31%) | 6 (5.66%) | 0 (0.00%) |
Take PrEP regularly | |||
Yes | 41 (59.42%) | 38 (58.46%) | 3 (75.00%) |
No | 20 (28.99%) | 20 (30.77%) | 0 (0.00%) |
DK/DA | 8 (11.59%) | 7 (10.77%) | 1 (25.00%) |
STI history in the last 12 months | |||
None | 52 (46.02%) | 49 (46.23%) | 3 (42.86%) |
Syphilis | 20 (17.70%) | 20 (18.87%) | 0 (0.00%) |
Chlamydia | 20 (17.70%) | 19 (17.92%) | 1 (14.29%) |
Gonorrhea | 24 (21.24%) | 22 (20.75%) | 2 (28.57%) |
Lymphogranuloma venereum | 1 (0.88%) | 1 (0.94%) | 0 (0.00%) |
Genital herpes | 3 (2.65%) | 3 (2.83%) | 0 (0.00%) |
Human papillomavirus | 5 (4.42%) | 5 (4.72%) | 0 (0.00%) |
Mycoplasma genitalium | 7 (6.19%) | 7 (6.60%) | 0 (0.00%) |
Hepatitis A | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
Hepatitis B | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
Hepatitis C | 3 (2.65%) | 2 (1.89%) | 1 (14.29%) |
Other STIs | 6 (5.31%) | 6 (5.66%) | 0 (0.00%) |
DK/DA | 3 (2.65%) | 1 (0.94%) | 2 (28.57%) |
Contact with a confirmed case of Mpox | |||
Yes | 28 (24.78%) | 25 (23.58%) | 3 (42.86%) |
No | 63 (55.75%) | 60 (56.60%) | 3 (42.86%) |
DK/DA | 22 (19.47%) | 21 (19.81%) | 1 (14.29%) |
Traveled in the last 30 days | |||
Yes | 53 (46.90%) | 50 (47.17%) | 3 (42.86%) |
No | 57 (50.44%) | 53 (50.00%) | 4 (57.14%) |
DK/DA | 3 (2.65%) | 3 (2.83%) | 0 (0.00%) |
Having received the Smallpox vaccine | |||
Yes, vaccinated in childhood | 7 (6.19%) | 6 (5.66%) | 1 (14.29%) |
Yes, vaccinated in the last 12 months | 13 (11.50%) | 12 (11.32%) | 1 (14.29%) |
No | 75 (66.37%) | 71 (66.98%) | 4 (57.14%) |
DK/DA | 18 (15.93%) | 17 (16.04%) | 1 (14.29%) |
Mpox Concern Level | |||
Extremely concerned | 40 (35.40%) | 38 (35.85%) | 2 (28.57%) |
Moderately concerned | 40 (35.40%) | 37 (34.91%) | 3 (42.86%) |
Somewhat concerned | 17 (15.04%) | 15 (14.15%) | 2 (28.57%) |
Slightly concerned | 6 (5.31%) | 6 (5.66%) | 0 (0.00%) |
Not at all concerned | 1 (0.88%) | 1 (0.94%) | 0 (0.00%) |
DK/DA | 9 (7.96%) | 9 (8.49%) | 0 (0.00%) |
Self-preceived probability of getting Mpox | |||
Very likely | 18 (15.93%) | 17 (16.04%) | 1 (14.29%) |
Likely | 35 (30.97%) | 31 (29.25%) | 4 (57.14%) |
Neither very nor unlikely | 29 (25.66%) | 27 (25.47%) | 2 (28.57%) |
Unlikely | 13 (11.50%) | 13 (12.26%) | 0 (0.00%) |
Very unlikely | 4 (3.54%) | 4 (3.77%) | 0 (0.00%) |
DK/DA | 14 (12.39%) | 14 (13.21%) | 0 (0.00%) |
